Clinical Trial Update: The Impact of Inhaled Furosemide and Perorally Administered Levodropropizine on Dyspnea in Patients With Respiratory Diseases [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update investigating inhaled furosemide and perorally administered levodropropizine for dyspnea in respiratory diseases; study phases 2 and 3 a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspnea

Drugs mentioned

• FUROSEMIDE (Furosemide)
• Levodropropizine (levodropropizine)

Snippet

Sponsor: University Hospital Hradec Kralove | Conditions: Dyspnea | Phase 2, Phase 3 | Status: RECRUITING